Funder
Ministry of Science, Technological Development and Innovation, Republic of Serbia
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. A randomized trial of the I-BFM-SG for the management of childhood non-B acute lymphoblastic leukemia (ALL IC-BFM 2009) (2009) Final version of therapy protocol from August-14-2009 [Internet]. https://www.bialaczka.org/wp-content/uploads/2016/10/ALLIC_BFM_2009.pdf. Accessed June 2023
2. Pillon M, Arico M, Mussolin L, Carraro E, Conter V, Sala A, Buffardi S, Garaventa A, D’Angelo P, Lo Nigro L, Santoro N, Piglione M, Lombardi A, Porta F, Cesaro S, Moleti ML, Casale F, Mura R, d’Amore ES, Basso G, Rosolen A (2015) Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma. Pediatr Blood Cancer 62(8):1388–1394. https://doi.org/10.1002/pbc.25469
3. International protocol for the treatment of childhood anaplastic large cell lymphoma (ALCL 99) (2000) [Internet]. https://www.skion.nl/workspace/uploads/alcl-99.pdf. Accessed June 2023
4. Zhang Y, Sun L, Chen X, Zhao L, Wang X, Zhao Z, Mei S (2022) A systematic review of population pharmacokinetic models of methotrexate. Eur J Drug Metab Pharmacokinet 47(2):143–164. https://doi.org/10.1007/s13318-021-00737-6
5. Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD (2016) Preventing and managing toxicities of high-dose methotrexate. Oncologist 21(12):1471–1482. https://doi.org/10.1634/theoncologist.2015-0164